Biotech News

Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference

Treace Medical Concepts (TMCI)Treace Medical ConceptsConference / presentation

PONTE VEDRA, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will highlight new

Related news

Treace Medical Concepts

Bunion and Midfoot Surgery Treace Medical Concepts develops orthopedic systems for the surgical correction of bunions and related midfoot deformities. Its products are designed to address the underlying three-dimensional alignment of the affected anatomy. Lapiplasty Platform The Lapiplasty procedure and associated instrumentation enable...

Recent company news

Stock data

Close
4.34 USD
Market cap
225.11M USD
Exchange
NASDAQ
Sector
MedTech
Location
United States